- Home
- MOV vs NPCE Comparison
MOV vs NPCE Comparison
Compare MOV & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOV
- NPCE
- Stock Information
- Founded
- MOV 1961
- NPCE 1997
- Country
- MOV United States
- NPCE United States
- Employees
- MOV N/A
- NPCE N/A
- Industry
- MOV Consumer Specialties
- NPCE Medical Specialities
- Sector
- MOV Consumer Discretionary
- NPCE Health Care
- Exchange
- MOV Nasdaq
- NPCE Nasdaq
- Market Cap
- MOV 339.1M
- NPCE 342.7M
- IPO Year
- MOV 1993
- NPCE 2021
- Fundamental
- Price
- MOV $19.61
- NPCE $10.92
- Analyst Decision
- MOV Strong Buy
- NPCE Strong Buy
- Analyst Count
- MOV 1
- NPCE 6
- Target Price
- MOV $31.50
- NPCE $16.67
- AVG Volume (30 Days)
- MOV 154.2K
- NPCE 165.0K
- Earning Date
- MOV 08-28-2025
- NPCE 11-11-2025
- Dividend Yield
- MOV 7.15%
- NPCE N/A
- EPS Growth
- MOV N/A
- NPCE N/A
- EPS
- MOV 0.77
- NPCE N/A
- Revenue
- MOV $655,597,000.00
- NPCE $88,570,000.00
- Revenue This Year
- MOV $1.98
- NPCE $22.13
- Revenue Next Year
- MOV N/A
- NPCE $6.07
- P/E Ratio
- MOV $25.39
- NPCE N/A
- Revenue Growth
- MOV 0.79
- NPCE 23.32
- 52 Week Low
- MOV $12.85
- NPCE $5.45
- 52 Week High
- MOV $22.20
- NPCE $18.98
- Technical
- Relative Strength Index (RSI)
- MOV 62.78
- NPCE 67.25
- Support Level
- MOV $18.60
- NPCE $9.76
- Resistance Level
- MOV $19.40
- NPCE $10.52
- Average True Range (ATR)
- MOV 0.43
- NPCE 0.44
- MACD
- MOV -0.11
- NPCE 0.04
- Stochastic Oscillator
- MOV 59.78
- NPCE 85.52
About MOV Movado Group Inc.
Movado Group Inc designs, develops, sources, markets, and distributes fine watches in the United States and internationally. It operates through the Watch and Accessory Brands and Company Stores segment. The Watch and Accessory Brands segment includes the designing, manufacturing, and distribution of watches and, to a lesser extent, jewelry and other accessories of quality owned brands and licensed brands. Its Company Stores segment includes the company's retail outlet locations in the United States and Canada. It generates maximum revenue from the Watch and Accessory Brands segment. Geographically, it derives the majority of its revenue from its international locations.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.